Main > > >MESOTHELIOMA. *

---

Malignant Pleural Mesothelioma. TREAT.:
NivoluMAb+IpilimuMAb.
USA Approval Date: 2020. 10.02.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 10.03.




Malignant Pleural Mesothelioma. TREAT.:
Tumor Treating Fields (TTF)+Pemetrexed +Pt ChemoTherapy.
CH & EU CE Mark Date: 2020. 11.11.
USA Approval Date : 2019. 05.23.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2021. 02.19.


>MESOTHELIOMA. *'s products
This section has no products